The company delivered a strong start to fiscal 2026 with significant first-quarter adjusted EBITDA growth of 61% year over year to $12 million, driven by consistent execution and disciplined cost management. A $50 million private placement of common stock closed in February 2026, resulting in the fixed annual interest rate dropping to 5% from 9% for a five-year period.
Cyborg Score Rationale
Adjusted EBITDA grew by 61% year-over-year, showcasing robust operational performance. However, leverage remains high with $455 million of debt outstanding with favorable 25-year maturity and 9.0% fixed rate, now reduced to 5%. EPS came in at -$0.90 compared to the forecasted -$0.69, missing analyst expectations.